Arrhythmia Alliance News & Events
Special supplement celebrates advances in cardiac pacing – a 60th anniversary update
Making promises for all our hearts
World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease. The annual campaign brings together individuals, families, communities and organisations around the world to participate in activities to take charge of their heart health and that of others. This year’s theme for World Heart Day is to make a promise... for my heart, for your heart, for all our hearts.
We’re supporting the Cardiovascular Health campaign with Media Planet UK
A Mother’s Mission to Educate the World About Arrhythmia
When Trudie Lobban’s daughter Francesca, now 29, was a baby, the girl had fainting episodes up to eight times a day. It took three years until Francesca was diagnosed with Reflex Anoxic Seizures (RAS), a condition that caused her heart to briefly stop.
5th World Heart and Brain Conference
We are pleased to invite the contributors across the globe on its "5th World Heart and Brain conference" which is slated at Abu Dhabi, UAE during September 24-26, 2018 around the theme "Fostering Heart and brain health world-wide" "It covers topics such as Cardiology, Neurology, Medicine, Medical imaging, Nuclear cardiology, Neuroscience, Stroke, Heart disease, Interventional Cardiology, Neuron Surgeon, Brain disorders, Dementia and other related disciplines”. Our Conference will provide a perfect platform addressing: Laudable talks by the top-notch of the global scientific community Sterling workshop sessions, Remarkable Awards and Global Recognition to meritorious Researchers, Global Networking with 50+ Countries, Novel Techniques to Benefit Your Research, Global Business and Networking Opportunities, Exquisite Platform for showcasing your products and International Sponsorship Join Heart and Brain 2018 and spend few days in amazing city of Abu Dhabi.
Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*
wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).
An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by right ventricular myocardial replacement and life-threatening ventricular arrhythmias. Desmosomal gene mutations are sometimes identified, but clinical and genetic diagnosis remains challenging. Desmosomal skin disorders can be caused by desmosomal gene mutations or autoantibodies. We sought to determine if anti-desmosome antibodies are present in subjects with ARVC.